Brind.

MarketBeat Releases Analyst Ratings and Comparisons for Phibro and Peers

2 reports, 2 independent Updated Oct 14
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

MarketBeat released new ratings for Phibro Animal Health. The platform also compared Phibro to other small-cap healthcare companies, including MediciNova and Tvardi Therapeutics. Reports noted that Phibro Animal Health has 99.3% institutional ownership and 48.5% insider ownership, compared to lower figures for its peers.

From themarketsdaily.com, dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The ratings and comparisons provide insight into the perceived investment strength of Phibro Animal Health relative to its competitors. For instance, one report noted that Phibro Animal Health has higher revenue and earnings than Tvardi Therapeutics. Phibro is a publicly listed company on Nasdaq.

From themarketsdaily.com, dailypolitical.com

Who's involved

  • MarketBeatAmerican personal finance blog that provides analyst ratings and market coverage
  • PhibroInternational physical commodities trading firm listed on Nasdaq
  • NasdaqAmerican fully electronic stock exchange where Phibro is listed
  • ZoetisAmerican animal health company whose product portfolio was acquired by Phibro

How it developed

Newest first. Tap a step to see who reported it.
  1. MediciNova is added to the list of small-cap healthcare companies covered by MarketBeat on Nasdaq.1 source
  2. MarketBeat released new ratings for Phibro.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped